Yi HM - Search Results

1

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.

Xiong J, Cheng S, Gao X, Yu SH, Dai YT, Huang XY, Zhong HJ, Wang CF, Yi HM, Zhang H, Cao WG, Li R, Tang W, Zhao Y, Xu PP, Wang L, Zhao WL. Xiong J, et al. Among authors: yi hm. Signal Transduct Target Ther. 2024 Mar 6;9(1):62. doi: 10.1038/s41392-024-01782-8. Signal Transduct Target Ther. 2024. PMID: 38448403 Free PMC article. Clinical Trial.

2

[Clinical application of split liver transplantation: a single center report of 203 cases].

Yang Q, Yi SH, Fu BS, Zhang T, Zeng KN, Feng X, Yao J, Tang H, Li H, Zhang J, Zhang YC, Yi HM, Lyu HJ, Liu JR, Luo GJ, Ge M, Yao WF, Ren FF, Zhuo JF, Luo H, Zhu LP, Ren J, Lyu Y, Wang KX, Liu W, Chen GH, Yang Y. Yang Q, et al. Among authors: yi hm. Zhonghua Wai Ke Za Zhi. 2024 Apr 1;62(4):324-330. doi: 10.3760/cma.j.cn112139-20231225-00297. Zhonghua Wai Ke Za Zhi. 2024. PMID: 38432674 Chinese.

3

CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression.

Shen YG, Ji MM, Yi HM, Shen R, Fu D, Cheng S, Huang CX, Wang L, Xu PP, Dou HJ, Zhao WL. Shen YG, et al. Among authors: yi hm. Clin Transl Med. 2024 Jan;14(1):e1532. doi: 10.1002/ctm2.1532. Clin Transl Med. 2024. PMID: 38193627 Free PMC article. No abstract available.

4

[Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].

Shen X, Yi HM, Li AQ, Ouyang BS, Dong L, Wang CF. Shen X, et al. Among authors: yi hm. Zhonghua Bing Li Xue Za Zhi. 2024 Jan 8;53(1):29-33. doi: 10.3760/cma.j.cn112151-20230823-00089. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 38178743 Chinese.

5

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.

Wang Y, Shi Q, Shi ZY, Tian S, Zhang MC, Shen R, Fu D, Dong L, Yi HM, Ouyang BS, Mu RJ, Cheng S, Wang L, Xu PP, Zhao WL. Wang Y, et al. Among authors: yi hm. Blood Adv. 2024 Apr 9;8(7):1587-1599. doi: 10.1182/bloodadvances.2023011425. Blood Adv. 2024. PMID: 38170757 Free PMC article.

6

Diagnostic performance and clinical impacts of metagenomic sequencing after allogeneic hematopoietic stem cell transplantation.

Xu CH, Chen X, Zhu GQ, Yi HM, Chen SL, Liu T, Yu YT, Zhang QH, Jiang EL, Feng SZ. Xu CH, et al. Among authors: yi hm. J Microbiol Immunol Infect. 2024 Feb;57(1):11-19. doi: 10.1016/j.jmii.2023.11.002. Epub 2023 Nov 28. J Microbiol Immunol Infect. 2024. PMID: 38065767 Free article.

7

[Clinical characteristics and efficacy analysis of 11 patients with primary cutaneous diffuse large B-cell lymphoma, leg type].

Yuan YX, Shi Q, He Y, Qiu HL, Yi HM, Dong L, Wang L, Cheng S, Xu PP, Zhao WL. Yuan YX, et al. Among authors: yi hm. Zhonghua Xue Ye Xue Za Zhi. 2023 Aug 14;44(8):690-693. doi: 10.3760/cma.j.issn.0253-2727.2023.08.015. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37803847 Free PMC article. Chinese. No abstract available.

8

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.

Xiong J, Dai YT, Wang WF, Zhang H, Wang CF, Yin T, Cheng S, Zhong HJ, Yu SH, Jiang L, Wang SY, Fang H, Zhang RH, Zhu Y, Yi HM, Jiang XF, Chen JY, Wang L, Xu PP, Chen SJ, Zhao WL. Xiong J, et al. Among authors: yi hm. Sci Bull (Beijing). 2023 Nov 15;68(21):2607-2619. doi: 10.1016/j.scib.2023.09.029. Epub 2023 Sep 22. Sci Bull (Beijing). 2023. PMID: 37798178 Free article.

9

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, Jiang XF, Song Q, Zhao Y, He Y, Li JF, Mu RJ, Fang H, Yu H, Xiong H, Li B, Chen SJ, Xu PP, Zhao WL. Zhang MC, et al. Among authors: yi hm. Cancer Cell. 2023 Oct 9;41(10):1705-1716.e5. doi: 10.1016/j.ccell.2023.09.004. Epub 2023 Sep 28. Cancer Cell. 2023. PMID: 37774697 Free article.

10

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial.

Shi Q, He Y, Yi HM, Mu RJ, Jiang XF, Fu D, Dong L, Qin W, Xu PP, Cheng S, Song Q, Chen SJ, Wang L, Zhao WL. Shi Q, et al. Among authors: yi hm. Cancer Commun (Lond). 2023 Aug;43(8):896-908. doi: 10.1002/cac2.12462. Epub 2023 Jul 4. Cancer Commun (Lond). 2023. PMID: 37403255 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page